Leia Rispoli, MD
Interventional Pain Medicine · Marina del Rey, CANPI 1679993406
Payments from drug & device makers
Across 526 payments — averaging $66.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$16K
- Boston Scientific$7K
- Medtronic$4K
- Abbott$2K
- Merz Pharmaceuticals, LLC$1K
- Nevro Corp.$1K
- plus $3K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 69 | $16,210 |
| Boston Scientific | 207 | $7,312 |
| Medtronic(2 entities) | 73 | $4,390 |
| Abbott | 59 | $2,295 |
| Merz Pharmaceuticals, LLC | 32 | $1,095 |
| Nevro Corp. | 14 | $1,060 |
| Biotronik NRO, Inc. | 16 | $542 |
| Curonix LLC | 11 | $467 |
| AbbVie(2 entities) | 3 | $185 |
| Brixton Biosciences, Inc. | 1 | $158 |
| Globus Medical | 4 | $143 |
| Vertiflex, Inc. | 2 | $122 |
| MML US, Inc. | 5 | $117 |
| Saluda Medical Americas, Inc. | 5 | $114 |
| Relievant Medsystems, Inc. | 4 | $112 |
| Stratus Medical, LLC | 2 | $112 |
| Vertex | 4 | $106 |
| SPR Therapeutics, Inc | 1 | $66 |
| Merz North America, Inc. | 2 | $65 |
| Ipsen Biopharmaceuticals, Inc | 2 | $57 |
| Pfizer | 2 | $45 |
| Lundbeck LLC | 2 | $35 |
| Vertos Medical, Inc. | 1 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| IBSA Pharma Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
How this compares
$34,944 in reported general payments places this provider in the 85th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Marina del Rey
- Akash BajajMarina del Rey$14K
- Sheldon JordanSanta Monica$3.1M
- Ezekiel FinkBeverly Hills$2.3M
- Matthew DotyOroville$1.3M
- Tim LeierRancho Mirage$749K
- Pragya GuptaEscondido$647K
- Michael Verdolinla Mesa$563K
- Standiford HelmOrange$476K
- Patrick BuchananCamarillo$453K
- Roy BrownlowSan Diego$452K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.